Houston M C
West J Med. 1987 Jun;146(6):701-4.
The calcium channel blocker nifedipine is an effective antihypertensive agent for the treatment of severe hypertension and hypertensive crises. It produces a prompt, predictable and consistent reduction in systemic arterial pressure with minimal adverse effects. The blood pressure reduction is inversely correlated with the pretreatment blood pressure level. Various nonparenteral administration forms-oral, sublingual, buccal and rectal-permit a versatile, noninvasive, cost-effective alternative to parenteral antihypertensive therapy and continuous hemodynamic monitoring. Blood pressure is reduced to the goal level in 98% of patients with a 10- to 20-mg dose of nifedipine. Hemodynamic changes are favorable and morbidity is uncommon.
钙通道阻滞剂硝苯地平是治疗重度高血压和高血压危象的一种有效抗高血压药物。它能迅速、可预测且持续地降低体循环动脉压,副作用极小。血压降低与治疗前血压水平呈负相关。多种非肠道给药形式——口服、舌下含服、颊部给药和直肠给药——为肠道外抗高血压治疗和持续血流动力学监测提供了一种通用、无创且经济高效的替代方法。10至20毫克剂量的硝苯地平可使98%的患者血压降至目标水平。血流动力学变化有利,且发病率不高。